posted on 2019-07-08, 09:01authored byK Nikopoulos, K Cisarova, M Quinodoz, H Koskiniemi-Kuendig, N Miyake, P Farinelli, AU Rehman, MI Khan, A Prunotto, M Akiyama, Y Kamatani, C Terao, F Miya, Y Ikeda, S Ueno, N Fuse, A Murakami, Y Wada, H Terasaki, K-H Sonoda, T Ishibashi, M Kubo, FPM Cremers, Z Kutalik, N Matsumoto, KM Nishiguchi, T Nakazawa, C Rivolta
Hereditary retinal degenerations (HRDs) are Mendelian diseases characterized by progressive blindness and caused by ultra-rare mutations. In a genomic screen of 331 unrelated Japanese patients, we identify a disruptive Alu insertion and a nonsense variant (p.Arg1933*) in the ciliary gene RP1, neither of which are rare alleles in Japan. p.Arg1933* is almost polymorphic (frequency = 0.6%, amongst 12,000 individuals), does not cause disease in homozygosis or heterozygosis, and yet is significantly enriched in HRD patients (frequency = 2.1%, i.e., a 3.5-fold enrichment; p-value = 9.2 × 10-5). Familial co-segregation and association analyses show that p.Arg1933* can act as a Mendelian mutation in trans with the Alu insertion, but might also associate with disease in combination with two alleles in the EYS gene in a non-Mendelian pattern of heredity. Our results suggest that rare conditions such as HRDs can be paradoxically determined by relatively common variants, following a quasi-Mendelian model linking monogenic and complex inheritance.
Funding
This work was supported by the following agencies. The Swiss National Science Foundation (grant #176097, to C.R.); the Rotterdamse Stichting Blindenbelangen, the Stichting voor Ooglijders and the Nelly Reef fund (to M.I.K. and F.P.M.C.); the Japan Agency for Medical Research and Development (grant #17ek0109213h0001) and the Japan Society for the Promotion of Science (grant #16K11315, to K.M.N.); Research on Measures for Intractable Diseases, Comprehensive Research on Disability Health and Welfare, the Strategic Research Program for Brain Science, and the Initiative on Rare and Undiagnosed Diseases (all to N.Ma.); the Japanese Agency for Medical Research and Development, Grants-in-Aid for Scientific Research (to N.Ma. and N.Mi.); the BioBank Japan Project, by the Japanese Ministry of Education, Culture, Sport, Science and Technology and the Japanese Agency for Medical Research and Development (to M.K.); the PhD Fellowship in Life Sciences (Faculty of Biology and Medicine, University of Lausanne), to M.Q. Most HRD patients were recruited from the Japanese Retinitis Pigmentosa Registry Project (JRPRP).
Data availability
The data supporting the findings of this study, as a whole, contain information that could
compromise the privacy/consent of the participants, therefore we provide the genotypes
of the cases analyzed as a summary statistics file containing aggregated data
(Supplementary Data 2). Genotypes of control Japanese individuals from the ToMMo
Japanese Reference Panel Project (3.5KJPN release, v20181105open) can be accessed at
https://jmorp.megabank.tohoku.ac.jp/201905/downloads. Data from the BioBank Japan
Project and the Tohoku University School of Medicine and Yokohama City University
Graduate School of Medicine is available upon request to the corresponding author,
pending authorization of the Centers that generated them and in agreement with their
specific IRB approvals.
Code availability
Processing of raw sequence files, variant calling, variant annotation, as well as all the
other analyses described in this work were performed using available and open source
software, as detailed in the Methods section. No custom code was therefore used, aside
from simple scripts integrating commands for such programs.